Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$36.81 - $48.12 $570,555 - $745,860
-15,500 Reduced 43.13%
20,440 $844,000
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $28,544 - $35,768
800 Added 2.28%
35,940 $1.48 Million
Q3 2022

Feb 14, 2023

BUY
$42.51 - $54.02 $586,638 - $745,476
13,800 Added 64.67%
35,140 $1.54 Million
Q3 2022

Nov 14, 2022

BUY
$42.51 - $54.02 $586,638 - $745,476
13,800 Added 64.67%
35,140 $1.54 Million
Q2 2022

Feb 14, 2023

BUY
$46.84 - $59.75 $42,156 - $53,775
900 Added 4.4%
21,340 $1.05 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $42,156 - $53,775
900 Added 4.4%
21,340 $1.05 Million
Q1 2022

Feb 14, 2023

SELL
$48.09 - $57.79 $706,923 - $849,513
-14,700 Reduced 41.83%
20,440 $1.16 Million
Q1 2022

May 13, 2022

SELL
$48.09 - $57.79 $16.3 Million - $19.6 Million
-339,881 Reduced 94.33%
20,440 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$47.19 - $62.68 $796,708 - $1.06 Million
16,883 Added 4.92%
360,321 $18.9 Million
Q3 2021

Nov 15, 2021

BUY
$56.91 - $67.81 $441,906 - $526,544
7,765 Added 2.31%
343,438 $20.6 Million
Q2 2021

Aug 13, 2021

SELL
$64.02 - $71.72 $2.18 Million - $2.45 Million
-34,095 Reduced 9.22%
335,673 $22.8 Million
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $24.1 Million - $30.8 Million
-452,428 Reduced 55.03%
369,768 $24.2 Million
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $13.6 Million - $17.8 Million
-314,314 Reduced 27.66%
822,196 $46.3 Million
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $1.37 Million - $1.76 Million
-28,990 Reduced 2.49%
1,136,510 $55.2 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $4.7 Million - $7.2 Million
108,064 Added 10.22%
1,165,500 $64.9 Million
Q1 2020

May 15, 2020

BUY
$32.82 - $81.13 $2.16 Million - $5.33 Million
65,674 Added 6.62%
1,057,436 $53.6 Million
Q4 2019

Feb 18, 2020

BUY
$60.96 - $77.7 $17.4 Million - $22.1 Million
284,735 Added 40.27%
991,762 $76.7 Million
Q3 2019

Nov 14, 2019

SELL
$55.78 - $68.08 $1.47 Million - $1.8 Million
-26,435 Reduced 3.6%
707,027 $44.8 Million
Q2 2019

Aug 13, 2019

SELL
$53.69 - $65.47 $6.57 Million - $8.01 Million
-122,293 Reduced 14.29%
733,462 $42.9 Million
Q1 2019

May 14, 2019

SELL
$44.53 - $58.9 $1.59 Million - $2.11 Million
-35,750 Reduced 4.01%
855,755 $48.6 Million
Q4 2018

Feb 13, 2019

SELL
$47.64 - $71.26 $1.09 Million - $1.63 Million
-22,843 Reduced 2.5%
891,505 $44.2 Million
Q3 2018

Nov 08, 2018

SELL
$52.03 - $71.41 $2.09 Million - $2.87 Million
-40,240 Reduced 4.22%
914,348 $64.9 Million
Q2 2018

Aug 13, 2018

BUY
$48.15 - $56.68 $451,165 - $531,091
9,370 Added 0.99%
954,588 $49.8 Million
Q1 2018

May 14, 2018

BUY
$46.03 - $61.28 $6.66 Million - $8.87 Million
144,743 Added 18.08%
945,218 $49.4 Million
Q4 2017

Feb 13, 2018

BUY
$50.58 - $60.79 $18 Million - $21.6 Million
355,908 Added 80.06%
800,475 $46.8 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $23.8 Million - $30.2 Million
444,567
444,567 $24.7 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.